Suppr超能文献

患有月经异常的多囊卵巢综合征女性的临床和生化特征

Clinical and Biochemical Characteristics in PCOS Women With Menstrual Abnormalities.

作者信息

Christodoulopoulou Vasiliki, Trakakis Eftihios, Pergialiotis Vasilios, Peppa Melpomeni, Chrelias Charalampos, Kassanos Dimitrios, Papantoniou Nikolaos

机构信息

3rd Department of Obstetrics and Gynaecology, Attiko Hospital, National and Kapodistrian University of Athens, Athens, Greece.

2nd Department of Internal Medicine, Research Institute and Diabetes Center, Athens University Medical School, Attikon University Hospital, Athens, Greece.

出版信息

J Family Reprod Health. 2016 Dec;10(4):184-190.

Abstract

The purpose of the present study was to examine the impact of menstrual cycle abnormalities among patients with polycystic ovary syndrome (PCOS) on biochemical and anthropometric characteristics. We conducted a prospective observational study of patients 17-35 years of age with PCOS that attended the department of Gynecological Endocrinology of our hospital. A total of 309 women with PCOS participated in the study. In total, 72.2% suffered from menstrual cycle disorders. In our study 15.1% of women were overweight and 24% were obese. Also, 36% of the sample had androgenetic alopecia and 56.4% had acne. According to the stepwise discriminant analysis, we observed that glucose displayed the strongest association to the menstrual status (F to eliminate = 14.13), followed by endometrial thickness (F to eliminate = 10.89), waist circumference (F to eliminate = 10.17), LH levels (F to eliminate = 8.15) and PRL (F to eliminate = 4.45). Significantly higher levels of LH and TSH and lower levels of prolactin were found in women with menstrual disorders compared to those with normal menstrual cycles. Fasting glucose was also considerably higher among these patients although markers of insulin resistance such as the Matsuda, Quicki and HOMA-IR indices did not differ. According to the findings of our study PCOS patients with menstrual disorders exhibit hormonal alterations and elevated fasting glucose. Future studies are needed in this field to corroborate our findings and determine the anthropometric and biochemical profile of patients with menstrual cycle irregularities.

摘要

本研究的目的是探讨多囊卵巢综合征(PCOS)患者月经周期异常对生化和人体测量学特征的影响。我们对我院妇科内分泌科就诊的17 - 35岁PCOS患者进行了一项前瞻性观察研究。共有309名PCOS女性参与了该研究。总体而言,72.2%的患者存在月经周期紊乱。在我们的研究中,15.1%的女性超重,24%的女性肥胖。此外,36%的样本有雄激素性脱发,56.4%的样本有痤疮。根据逐步判别分析,我们观察到血糖与月经状态的关联最强(剔除F值 = 14.13),其次是子宫内膜厚度(剔除F值 = 10.89)、腰围(剔除F值 = 10.17)、促黄体生成素(LH)水平(剔除F值 = 8.15)和催乳素(PRL)(剔除F值 = 4.45)。与月经周期正常的女性相比,月经紊乱的女性LH和促甲状腺激素(TSH)水平显著升高,催乳素水平降低。这些患者的空腹血糖也明显更高,尽管诸如松田、奎基和稳态模型评估胰岛素抵抗(HOMA - IR)指数等胰岛素抵抗指标并无差异。根据我们的研究结果,月经紊乱的PCOS患者存在激素改变和空腹血糖升高的情况。该领域需要进一步的研究来证实我们的发现,并确定月经周期不规律患者的人体测量学和生化特征。

相似文献

2
Subclinical hypothyroidism does not influence the metabolic and hormonal profile of women with PCOS.
Horm Mol Biol Clin Investig. 2017 Jun 23;31(3):/j/hmbci.2017.31.issue-3/hmbci-2016-0058/hmbci-2016-0058.xml. doi: 10.1515/hmbci-2016-0058.
5
[Exploration of the classification of polycystic ovarian syndrome].
Zhonghua Fu Chan Ke Za Zhi. 2006 Oct;41(10):684-8.
6
Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
J Obstet Gynaecol. 2019 Oct;39(7):975-980. doi: 10.1080/01443615.2019.1581754. Epub 2019 May 7.
7
The impact of mild hypercholesterolemia on glycemic and hormonal profiles, menstrual characteristics and the ovarian morphology of women with polycystic ovarian syndrome.
Horm Mol Biol Clin Investig. 2018 Mar 29;34(3):/j/hmbci.2018.34.issue-3/hmbci-2018-0002/hmbci-2018-0002.xml. doi: 10.1515/hmbci-2018-0002.
8
Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS.
Arch Gynecol Obstet. 2013 Oct;288(4):905-10. doi: 10.1007/s00404-013-2833-9. Epub 2013 Apr 4.

引用本文的文献

本文引用的文献

1
Serum adiponectin is independently associated with the metabolic syndrome in Hong Kong, Chinese women with polycystic ovary syndrome.
Gynecol Endocrinol. 2016;32(5):390-4. doi: 10.3109/09513590.2015.1126708. Epub 2015 Dec 24.
3
Lipid accumulation product is associated with metabolic syndrome in women with polycystic ovary syndrome.
Hormones (Athens). 2016 Jan-Mar;15(1):35-44. doi: 10.14310/horm.2002.1592.
4
Adiponectin as serum biomarker of insulin resistance in patients with polycystic ovarian syndrome.
Gynecol Endocrinol. 2015 Jun;31(6):473-6. doi: 10.3109/09513590.2015.1008445. Epub 2015 Apr 17.
5
Menstrual cycle alterations during adolescence: early expression of metabolic syndrome and polycystic ovary syndrome.
J Pediatr Adolesc Gynecol. 2014 Dec;27(6):335-41. doi: 10.1016/j.jpag.2014.01.002. Epub 2014 Sep 23.
7
Cardiovascular Risk in Women With PCOS.
Int J Endocrinol Metab. 2012 Fall;10(4):611-8. doi: 10.5812/ijem.4020. Epub 2012 Sep 30.
9
Endocrine and metabolic characteristics of polycystic ovary syndrome in Chinese women with different phenotypes.
Clin Endocrinol (Oxf). 2012 Mar;76(3):425-30. doi: 10.1111/j.1365-2265.2011.04194.x.
10
The lipid accumulation product is associated with impaired glucose tolerance in PCOS women.
J Clin Endocrinol Metab. 2011 Jun;96(6):E986-90. doi: 10.1210/jc.2011-0031. Epub 2011 Apr 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验